1. Academic Validation
  2. Development of Novel 1,2,3,4-Tetrahydroquinoline Scaffolds as Potent NF-κB Inhibitors and Cytotoxic Agents

Development of Novel 1,2,3,4-Tetrahydroquinoline Scaffolds as Potent NF-κB Inhibitors and Cytotoxic Agents

  • ACS Med Chem Lett. 2016 Feb 16;7(4):385-90. doi: 10.1021/acsmedchemlett.6b00004.
Hyeju Jo 1 Minho Choi 1 Arepalli Sateesh Kumar 1 Yeongeun Jung 1 Sangeun Kim 1 Jieun Yun 2 Jong-Soon Kang 2 Youngsoo Kim 1 Sang-Bae Han 1 Jae-Kyung Jung 1 Jungsook Cho 3 Kiho Lee 4 Jae-Hwan Kwak 5 Heesoon Lee 1
Affiliations

Affiliations

  • 1 Department of Pharmacy, Chungbuk National University , Chungbuk 362-763, Republic of Korea.
  • 2 Korea Research Institute of Bioscience and Biotechnology , Ochang 363-883, Republic of Korea.
  • 3 College of Pharmacy, Dongguk University , Goyang 410-773, Republic of Korea.
  • 4 College of Pharmacy, Korea University , Sejong 339-700, Republic of Korea.
  • 5 College of Pharmacy, Kyungsung University , Busan 608-736, Republic of Korea.
Abstract

1,2,3,4-Tetrahydroquinolines have been identified as the most potent inhibitors of LPS-induced NF-κB transcriptional activity. To discover new molecules of this class with excellent activities, we designed and synthesized a series of novel derivatives of 1,2,3,4-tetrahydroquinolines (4a-g, 5a-h, 6a-h, and 7a-h) and bioevaluated their in vitro activity against human Cancer cell lines (NCI-H23, ACHN, MDA-MB-231, PC-3, NUGC-3, and HCT 15). Among all synthesized scaffolds, 6g exhibited the most potent inhibition (53 times that of a reference compound) of LPS-induced NF-κB transcriptional activity and the most potent cytotoxicity against all evaluated human Cancer cell lines.

Keywords

1,2,3,4-Tetrahydroquinolines; NF-κB inactivation; human cancer cell lines; in vitro cytotoxicity.

Figures